PDSB

PDS Biotechnology Corporation

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.98

Price (1 Year)

$1.44 $0.21

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %4.6 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers.

Website

Analysis (Turkish): PDSB Hissesi Caiz mi, Helal mi? PDS Biotechnology Corporation Katılım Analizi